Resmed (RSMDF) Cash & Equivalents Growth (3y) (2012 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 32.23% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 86.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.12% |
| Mar 31, 2026 | 93.87% |
| Dec 31, 2025 | 77.55% |
| Sep 30, 2025 | 88.33% |
| Jun 30, 2025 | 64.10% |
| Mar 31, 2025 | 66.58% |
| Dec 31, 2024 | 38.97% |
| Sep 30, 2024 | 15.58% |
| Jun 30, 2024 | -6.89% |
| Mar 31, 2024 | 1.04% |
| Dec 31, 2023 | -6.34% |
| Sep 30, 2023 | -20.83% |
| Jun 30, 2023 | -21.05% |
| Mar 31, 2023 | -13.56% |
| Dec 31, 2022 | 7.45% |
| Sep 30, 2022 | 6.36% |
| Jun 30, 2022 | 22.99% |
| Mar 31, 2022 | 11.26% |
| Dec 31, 2021 | 9.17% |
| Sep 30, 2021 | 6.26% |